News
The BREAKWATER study enrolled patients with newly diagnosed colon cancer that harbors a mutation called BRAF 600E that makes ...
Results released Friday show itepekimab succeeded in one Phase 3 trial but failed in a second, sinking shares of both partner ...
LONDON, GREATER LONDON, UNITED KINGDOM, May 30, 2025 /EINPresswire.com/ -- What Is The Forecasted Growth Of The Sarcoidosis Market? The global sarcoidosis market has witnessed rapid growth in recent ...
Amgen's Nplate, which treats low blood platelet counts caused by an autoimmune condition, was highly effective at preventing ...
AstraZeneca Pharma shares rose on receiving nod from the CDSCO, to import for sale and distribution of Benralizumab 30 mg/ml ...
Bangalore: AstraZeneca Pharma India Limited has received regulatory approval from the Central Drugs Standard Control ...
Introduction Oncology drugs are medications used to prevent or treat cancer. These include chemotherapy, targeted therapy, immunotherapy, and h ...
Several companies are advancing treatments for anal cancer, including Merck (KEYTRUDA), BioMimetix (BMX-001), Novartis (KFA115), and Bicara Therapeutics (BCA101), among others. As immunotherapy ...
Drugmakers are turning to biomarkers, like folate receptor alpha, and even cell therapies to tackle this deadly cancer in new ...
A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by ...
AstraZeneca India Pharma receives government approval for import and distribution of lung cancer medication Osimertinib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results